Chicago Partners Investment Group’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,958
| Closed | -$44.1K | – | 744 |
|
|
2024
Q1 | $44.1K | Sell |
13,958
-4,357
| -24% | -$13.8K | ﹤0.01% | 725 |
|
|
2023
Q4 | $59.2K | Buy |
18,315
+4,736
| +35% | +$15.3K | ﹤0.01% | 685 |
|
|
2023
Q3 | $44.9K | Buy |
+13,579
| New | +$44.9K | ﹤0.01% | 644 |
|
|
2023
Q2 | – | Sell |
-12,332
| Closed | -$46.6K | – | 684 |
|
|
2023
Q1 | $46.6K | Sell |
12,332
-6,347
| -34% | -$24K | ﹤0.01% | 650 |
|
|
2022
Q4 | $109K | Buy |
18,679
+7,594
| +69% | +$44.5K | 0.01% | 615 |
|
|
2022
Q3 | $72K | Buy |
+11,085
| New | +$72K | 0.01% | 570 |
|
|
2022
Q1 | – | Sell |
-17,960
| Closed | -$92K | – | 564 |
|
|
2021
Q4 | $92K | Buy |
17,960
+3,156
| +21% | +$16.2K | 0.01% | 551 |
|
|
2021
Q3 | $199K | Buy |
+14,804
| New | +$199K | 0.01% | 553 |
|